Published in Lab Business Week, January 1st, 2006
The investment round was led by Boulder, Colorado-based Skyland Capital, which was joined by four previous investors - Future Capital AG (Frankfurt, Germany), Lafayette Equity Fund, LP, Merck Capital Ventures, LLC, a subsidiary of Merck & Co., Inc., and 3i, a leading international venture capital company. Aegis has received more than $25 million in funding to date.
"With new capital and an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.